End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.8 TWD | 0.00% | 0.00% | -14.62% |
03-19 | Sinew Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sinew Pharma Inc.(TPEX:6634) added to S&P Global BMI Index | CI |
Sales 2022 | 0.33 10.69 0.45 | Sales 2023 | - | Capitalization | 4.8B 156B 6.56B |
---|---|---|---|---|---|
Net income 2022 | -140M -4.56B -191M | Net income 2023 | -171M -5.57B -234M | EV / Sales 2022 | 18,117,189,024 x |
Net cash position 2022 | 1.38B 45.08B 1.89B | Net cash position 2023 | 1.27B 41.25B 1.73B | EV / Sales 2023 | - |
P/E ratio 2022 |
-51.9
x | P/E ratio 2023 |
-27.9
x | Employees | 52 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.59% |
Current month | -15.25% | ||
1 month | -13.86% | ||
3 months | -12.42% | ||
6 months | -9.97% | ||
Current year | -14.62% |
Managers | Title | Age | Since |
---|---|---|---|
Kai Min Zhu
CEO | Chief Executive Officer | - | 14-06-17 |
Tzu Wen Chen
DFI | Director of Finance/CFO | - | - |
Cheng Hui Hsiung
CTO | Chief Tech/Sci/R&D Officer | - | 14-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chih Chuan Chen
BRD | Director/Board Member | - | - |
Li Chun Han
BRD | Director/Board Member | 66 | 19-06-26 |
Tu Mu Kuo
BRD | Director/Board Member | - | 19-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 57.8 | 0.00% | 43,968 |
24-04-25 | 57.8 | +1.40% | 24,048 |
24-04-24 | 57 | -1.55% | 53,705 |
24-04-23 | 57.9 | +1.94% | 45,848 |
24-04-22 | 56.8 | -1.73% | 48,190 |
End-of-day quote Taipei Exchange, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-14.62% | 126M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 6634 Stock